GFAP and Alzheimer disease: Therefore, it would be interesting to further study HO-1 localization and distribution in the hippocampus of AD human samples, of much more relevance than the mouse model and, where according to our results in mice and those from Schipper and co-workers, was the brain region in which HO-1 was significantly increased in GFAP-positive astrocytes.